Pimstone N R, Tenhunen R, Seitz P T, Marver H S, Schmid R
J Exp Med. 1971 Jun 1;133(6):1264-81. doi: 10.1084/jem.133.6.1264.
Recent studies have identified and characterized the enzymatic mechanism by which hemoglobin-heme is converted to bilirubin. Under physiologic conditions the enzyme system, microsomal heme-oxygenase, is most active in the spleen followed by the liver and bone marrow, all of which are tissues that normally are involved in the sequestration and metabolism of red cells. Indirect evidence suggested that the reticuloendothelial system is important in this process. To test this hypothesis, conversion of heme to bilirubin was studied in macrophages obtained by chemical or immunological means from the peritoneal cavity or from the lungs of rodents. Homogenates of pure populations of these cells were devoid of heme-oxygenase activity, unless before harvesting the macrophages had been exposed to methemalbumin, microcrystalline hemin, or hemoglobin in vivo. In macrophages exposed to heme pigments, the specific activity of heme-oxygenase was far in excess of that in the spleen or liver. Enzyme activity was also present in the granulomatous tissue surrounding subcutaneous hematomas. The heme-oxygenase system in macrophages resembles that in the spleen and liver in that it is localized in the microsomal fraction, has an absolute requirement for molecular oxygen and NADPH, is inhibited by carbon monoxide, and has a similar K(m). These findings indicate that cells of the reticuloendothelial system, presumably including the Kupffer cells of the liver and the macrophages of the spleen, possess the enzymatic machinery for converting hemoglobin-heme to bilirubin. The reaction is a mixed function oxidation, probably involving cytochrome P450 as the terminal oxidase. Enzyme activity in macrophages is capable of regulatory adaptation in response to substrate loads. In the standard assay system for the enzyme, disappearance of heme always was in excess of the amount of bilirubin formed, suggesting the simultaneous presence of alternate routes of heme degradation not involving bilirubin as an end product or intermediate.
最近的研究已经确定并描述了血红蛋白 - 血红素转化为胆红素的酶促机制。在生理条件下,酶系统——微粒体血红素加氧酶,在脾脏中活性最高,其次是肝脏和骨髓,所有这些组织通常都参与红细胞的隔离和代谢。间接证据表明网状内皮系统在这一过程中很重要。为了验证这一假设,研究了通过化学或免疫方法从啮齿动物的腹腔或肺部获得的巨噬细胞中血红素向胆红素的转化。这些细胞的纯群体匀浆缺乏血红素加氧酶活性,除非在收获巨噬细胞之前,它们在体内已暴露于高铁血红蛋白、微晶血红素或血红蛋白。在暴露于血红素色素的巨噬细胞中,血红素加氧酶的比活性远远超过脾脏或肝脏中的比活性。酶活性也存在于皮下血肿周围的肉芽肿组织中。巨噬细胞中的血红素加氧酶系统与脾脏和肝脏中的相似,因为它定位于微粒体部分,绝对需要分子氧和NADPH,被一氧化碳抑制,并且具有相似的米氏常数(K(m))。这些发现表明网状内皮系统的细胞,可能包括肝脏的库普弗细胞和脾脏的巨噬细胞,拥有将血红蛋白 - 血红素转化为胆红素的酶机制。该反应是一种混合功能氧化反应,可能涉及细胞色素P450作为末端氧化酶。巨噬细胞中的酶活性能够响应底物负荷进行调节适应。在该酶的标准测定系统中,血红素的消失总是超过形成的胆红素量,这表明同时存在不涉及胆红素作为终产物或中间产物的血红素降解的替代途径。